Results 91 - 100 of 213 : Previous 6 7 8 9 10 11 12 13 14 Next
Schering-Plough Has No Love for the Media
The drug company pushes on after the Enhance trials.
The pharmaceutical's settlement ends a government probe.
The pharmaceutical issues guidance for the coming year.
Cash may be king in this market
PDL BioPharma Regroups, Piece by Piece
The company still brings in plenty of money, despite selling off assets.
Best International Stock: Teva Pharmaceutical
Come on and take a free ride.
AstraZeneca's Trying to Get Healthier
The big pharma tries to get back on track.
Wyeth launches a generic version of its own drug.
One Last Look at Pre-Enhance Merck
Investors care more about the drugmaker's future than its Q4 results.
Icahn Tries to Board USS Biogen
Carl Icahn attempts a board shakeup at Biogen.
Results 91 - 100 of 213 : Previous 6 7 8 9 10 11 12 13 14 Next